Kathy Niakan

Last updated
Kathy Niakan
Kathy Niakan on Charles Wright Academy.jpg
Niakan as Charles Wright Academy Alum of the Year in 2016
Born1977
Memphis, Tennessee, USA [1]
NationalityAmerican  [1]
EducationPhD in stem cell research
Alma mater University of Washington, University of California, Los Angeles
Known forOne of the 100 most influential people in the world by Time magazine in April 2016. [2]
Scientific career
FieldsStem cell biology
Institutions Francis Crick Institute

Kathy Niakan is a developmental biologist, working in human developmental and stem cell biology. In 2016 she became the first scientist in the world to gain regulatory approval to edit the genomes of human embryos for research. [3]

Contents

Niakan was named as one of the 100 most influential people in the world by Time magazine in April 2016. [2]

Biography

Kathy Niakan obtained a BSc in cell and molecular biology and a BA in English literature from the University of Washington. In 2005, Niakan obtained her PhD in stem cell and developmental biology from the University of California, Los Angeles, where she worked in the laboratory of Edward McCabe. [4] She went on to be a research fellow with Kevin Eggan at Harvard University, working with human and mouse stem cells to study human embryogenesis and cell potency. She then moved to the University of Cambridge Anne McLaren Laboratory for Stem Cell Biology in the Cambridge Biomedical Campus where she continued to investigate the molecular basis of early cell development in humans and mice. [5] In 2013, Niakan became a group leader at the MRC National Institute for Medical Research (NIMR) in London. Since 2015, she has been a group leader at the Francis Crick Institute, [4] the successor institute to the NIMR. [6]

She was a finalist in the inaugorary UK Blavatnik Awards for Young Scientists in 2019. [7]

In 2021, Professor Kathy Niakan was appointed as an honorary group leader in the Epigenetics research programme as part of the Babraham Institute. The Babraham Institute pioneers world-changing scientific developments, and focuses on cellular signalling, gene regulation, immunology, and the impact of epigenetic regulation at different stages of life. This new appointment and leadership position will hopefully allow Kathy to collaborate with others in her field and continue vital research. [8]

Research

At the Francis Crick Institute she is investigating the mechanisms of lineage specification in human embryos and stem cells. [5]

In February 2016 Niakan was given the go-ahead by the UK Human Fertilisation and Embryology Authority to genetically modify human embryos. The embryos were to be destroyed after seven days. [9] She planned to use the CRISPR technique to answer questions like what genetic faults cause some women to miscarry, what causes infertility and what is crucial for a healthy embryo. [5] [10] In 2017 her lab published the first major study using CRISPR-Cas9 in human embryos in Nature, demonstrating that the transcription factor Oct4 is essential for fetal development. [11]

In addition to her pioneering research, Professor Niakan has engaged with policy makers, funders and the public to provide expert advice on genome editing.

Related Research Articles

<span class="mw-page-title-main">Embryo</span> Multicellular diploid eukaryote in its earliest stage of development

An embryo is an initial stage of development of a multicellular organism. In organisms that reproduce sexually, embryonic development is the part of the life cycle that begins just after fertilization of the female egg cell by the male sperm cell. The resulting fusion of these two cells produces a single-celled zygote that undergoes many cell divisions that produce cells known as blastomeres. The blastomeres are arranged as a solid ball that when reaching a certain size, called a morula, takes in fluid to create a cavity called a blastocoel. The structure is then termed a blastula, or a blastocyst in mammals.

<span class="mw-page-title-main">Cellular differentiation</span> Developmental biology

Cellular differentiation is the process in which a stem cell changes from one type to a differentiated one. Usually, the cell changes to a more specialized type. Differentiation happens multiple times during the development of a multicellular organism as it changes from a simple zygote to a complex system of tissues and cell types. Differentiation continues in adulthood as adult stem cells divide and create fully differentiated daughter cells during tissue repair and during normal cell turnover. Some differentiation occurs in response to antigen exposure. Differentiation dramatically changes a cell's size, shape, membrane potential, metabolic activity, and responsiveness to signals. These changes are largely due to highly controlled modifications in gene expression and are the study of epigenetics. With a few exceptions, cellular differentiation almost never involves a change in the DNA sequence itself. However, metabolic composition does get altered quite dramatically where stem cells are characterized by abundant metabolites with highly unsaturated structures whose levels decrease upon differentiation. Thus, different cells can have very different physical characteristics despite having the same genome.

<span class="mw-page-title-main">Oct-4</span> Mammalian protein found in Homo sapiens

Oct-4, also known as POU5F1, is a protein that in humans is encoded by the POU5F1 gene. Oct-4 is a homeodomain transcription factor of the POU family. It is critically involved in the self-renewal of undifferentiated embryonic stem cells. As such, it is frequently used as a marker for undifferentiated cells. Oct-4 expression must be closely regulated; too much or too little will cause differentiation of the cells.

<span class="mw-page-title-main">Designer baby</span> Genetically modified human embryo

A designer baby is a baby whose genetic makeup has been selected or altered, often to exclude a particular gene or to remove genes associated with disease. This process usually involves analysing a wide range of human embryos to identify genes associated with particular diseases and characteristics, and selecting embryos that have the desired genetic makeup; a process known as preimplantation genetic diagnosis. Screening for single genes is commonly practiced, and polygenic screening is offered by a few companies. Other methods by which a baby's genetic information can be altered involve directly editing the genome before birth, which is not routinely performed and only one instance of this is known to have occurred as of 2019, where Chinese twins Lulu and Nana were edited as embryos, causing widespread criticism.

In biology, reprogramming refers to erasure and remodeling of epigenetic marks, such as DNA methylation, during mammalian development or in cell culture. Such control is also often associated with alternative covalent modifications of histones.

<span class="mw-page-title-main">Rudolf Jaenisch</span> German biologist

Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. Jaenisch has focused on creating genetically modified mice to study cancer, epigenetic reprogramming and neurological diseases.

<span class="mw-page-title-main">Inner cell mass</span> Early embryonic mass that gives rise to the fetus

The inner cell mass (ICM) or embryoblast is a structure in the early development of an embryo. It is the mass of cells inside the blastocyst that will eventually give rise to the definitive structures of the fetus. The inner cell mass forms in the earliest stages of embryonic development, before implantation into the endometrium of the uterus. The ICM is entirely surrounded by the single layer of trophoblast cells of the trophectoderm.

<span class="mw-page-title-main">Janet Rossant</span> Biologist

Janet Rossant, is a developmental biologist well known for her contributions to the understanding of the role of genes in embryo development. She is a world renowned leader in developmental biology. Her current research interests focus on stem cells, molecular genetics, and developmental biology. Specifically, she uses cellular and genetic manipulation techniques to study how genes control both normal and abnormal development of early mouse embryos. Rossant has discovered information on embryo development, how multiple types of stem cells are established, and the mechanisms by which genes control development. In 1998, her work helped lead to the discovery of the trophoblast stem cell, which has assisted in showing how congenital anomalies in the heart, blood vessels, and placenta can occur.

<span class="mw-page-title-main">Genetically modified animal</span> Animal that has been genetically modified

Genetically modified animals are animals that have been genetically modified for a variety of purposes including producing drugs, enhancing yields, increasing resistance to disease, etc. The vast majority of genetically modified animals are at the research stage while the number close to entering the market remains small.

Edith Heard is a British-French researcher in epigenetics who has been serving as the Director General of the European Molecular Biology Laboratory (EMBL) since January 2019. She is also Professor at the Collège de France, holding the Chair of Epigenetics and Cellular Memory.

The International Society for Stem Cell Research (ISSCR) is an independent 501(c)(3) nonprofit organization based in Evanston, Illinois, United States. The organization's mission is to promote excellence in stem cell science and applications to human health.

<span class="mw-page-title-main">Jim Cuthbert Smith</span>

Sir James Cuthbert Smith is Director of Science at the Wellcome Trust, Senior Group Leader at the Francis Crick Institute and President of the Council at Zoological Society of London.

Centre for Genomic Regulation

The Centre for Genomic Regulation is a biomedical and genomics research centre based on Barcelona. Most of its facilities and laboratories are located in the Barcelona Biomedical Research Park, in front of Somorrostro beach.

Magdalena Żernicka-Goetz is a Polish-British developmental biologist. She is Professor of Mammalian Development and Stem Cell Biology in the Department of Physiology, Development and Neuroscience and Fellow of Sidney Sussex College, Cambridge. She also serves as Bren Professor of Biology and Biological Engineering at California Institute of Technology (Caltech).

Human germline engineering is the process by which the genome of an individual is edited in such a way that the change is heritable. This is achieved by altering the genes of the germ cells, which then mature into genetically modified eggs and sperm. For safety, ethical, and social reasons, there is broad agreement among the scientific community and the public that germline editing for reproduction is a red line that should not be crossed at this point in time. There are differing public sentiments, however, on whether it may be performed in the future depending on whether the intent would be therapeutic or non-therapeutic.

Davor Solter is a Yugoslavian-born developmental biologist, particularly known for his pioneering work on mammalian genomic imprinting. He is Emeritus Member and Director, Max Planck Institute of Immunobiology and Epigenetics; Visiting International Professor, Siriraj Center for Excellence in Stem Cell Research, Mahidol University, Thailand; and Visiting Professor, University of Zagreb Medical School.

Antonio Jesus Giraldez is a Spanish developmental biologist and RNA researcher at Yale University School of Medicine, where he serves as chair of the department of genetics and Fergus F. Wallace Professor of Genetics. He is also affiliated with the Yale Cancer Center and the Yale Stem Cell Center.

<span class="mw-page-title-main">He Jiankui affair</span> 2018 scientific and bioethical controversy

The He Jiankui affair is a scientific and bioethical controversy concerning the use of genome editing following its first use on humans by Chinese scientist He Jiankui, who edited the genomes of human embryos in 2018. He became widely known on 26 November 2018 after he announced that he had created the first human genetically edited babies. He was listed in the Time's 100 most influential people of 2019. The affair led to ethical and legal controversies, resulting in the indictment of He and two of his collaborators, Zhang Renli and Qin Jinzhou. He eventually received widespread international condemnation.

<span class="mw-page-title-main">He Jiankui</span> Chinese scientist (born 1984)

He Jiankui is a Chinese biophysicist who was an associate professor in the Department of Biology of the Southern University of Science and Technology (SUSTech) in Shenzhen, China. Earning his Ph.D. from Rice University in Texas on protein evolution, including that of CRISPR, He learned gene-editing techniques (CRISPR/Cas9) as a postdoctoral researcher at Stanford University in California.

<span class="mw-page-title-main">CRISPR gene editing</span> Gene editing method

CRISPR gene editing is a genetic engineering technique in molecular biology by which the genomes of living organisms may be modified. It is based on a simplified version of the bacterial CRISPR-Cas9 antiviral defense system. By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added in vivo.

References

  1. 1 2 "Dr Kathy Niakan honoured by TIME magazine".
  2. 1 2 Doudna, Jennfer (2016-04-21). "Kathy Niakan". The World’s 100 Most Influential People. Time Magazine. Retrieved 2016-06-11.
  3. Callaway, Ewen (2016). "UK scientists gain licence to edit genes in human embryos". Nature. 530 (7588): 18. Bibcode:2016Natur.530...18C. doi: 10.1038/nature.2016.19270 . PMID   26842037.
  4. 1 2 "Kathy Niakan". Crick. Retrieved 2019-02-15.
  5. 1 2 3 "Kathy Niakan: Biography". Francis Crick Institute. Retrieved 15 February 2016.
  6. "Our founders". Crick. Retrieved 2019-02-15.
  7. "Kathy Niakan | Blavatnik Awards for Young Scientists". blavatnikawards.org. Retrieved 2019-01-10.
  8. "Epigenetics programme welcomes Professor Kathy Niakan as honorary group leader | Babraham Institute". www.babraham.ac.uk. Retrieved 2021-10-03.
  9. Gallagher, James (February 2016). "Scientists get 'gene editing' go-ahead". BBC News. Retrieved 15 February 2016.
  10. Walsh, Fergus (2016-06-06). "Gene editing technique could transform future". BBC News. Retrieved 2016-06-11.
  11. Fogarty, Norah M. E.; McCarthy, Afshan; Snijders, Kirsten E.; Powell, Benjamin E.; Kubikova, Nada; Blakeley, Paul; Lea, Rebecca; Elder, Kay; Wamaitha, Sissy E. (2017-09-20). "Genome editing reveals a role for OCT4 in human embryogenesis". Nature. 550 (7674): 67–73. Bibcode:2017Natur.550...67F. doi:10.1038/nature24033. ISSN   0028-0836. PMC   5815497 . PMID   28953884.